Categories Earnings, Health Care
Earnings Summary: Highlights of IDEXX Laboratories’ Q3 2023 earnings
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, has reported financial results for the third quarter of 2023.
- The company reported revenues of $916 million for the third quarter of 2023, an increase of 9%; organic revenue growth was 8%
- Among the business divisions, Companion Animal Group revenue grew 9% and Water revenue rose 9%; CAG Diagnostics revenue was up 10%
- Third-quarter earnings per share were $2.53, which is up 18% on a reported basis and 16% on a comparable basis
- Gross profits increased by 8% both as reported and on a comparable basis, while gross margin decreased by 30 basis points to 59.9%
- Operating margin was 30.1% in the September quarter, higher than the prior year by 100 basis points
- The company expects full-year revenues to grow in the range of 7.9%-8.4% as reported and 8.3%-8.8% organically
- Full-year reported operating margin is expected to be in the range of 29.6% to 29.8%
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
BLK Q4 Preview: BlackRock appears poised for another earnings beat
BlackRock, Inc. (NYSE: BLK), the largest asset management company, is set to publish its fourth-quarter 2025 results next week. The update is expected to shed light on how the firm’s
A look at Best Buy’s (BBY) progress on its growth strategy
Shares of Best Buy Co., Inc. (NYSE: BBY) fell over 3% on Wednesday. The stock has dropped 17% over the past 12 months. The consumer electronics retailer delivered sales and
